RT Journal Article
SR Electronic
T1 Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.05.20123745
DO 10.1101/2020.06.05.20123745
A1 Desmet, Tania
A1 De Paepe, Peter
A1 Boelens, Jerina
A1 Coorevits, Liselotte
A1 Padalko, Elizaveta
A1 Vandendriessche, Stien
A1 Leroux-Roels, Isabel
A1 Aerssens, Annelies
A1 Callens, Steven
A1 Van Braeckel, Eva
A1 Malfait, Thomas
A1 Vermassen, Frank
A1 Verhasselt, Bruno
YR 2020
UL http://medrxiv.org/content/early/2020/06/07/2020.06.05.20123745.abstract
AB Background Early 2020, a COVID-19 epidemic became a public health emergency of international concern. To address this pandemic broad testing with an easy, comfortable and reliable testing method is of utmost concern. The nasopharyngeal (NP) swab sampling is the reference method though hampered by international supply shortages. A new oropharyngeal/nasal (OP/N) sampling method was investigated using the more readily available throat swab.Methods In this prospective observational study 36 COVID-19 patients were tested with both a NP and combined OP/N swab for SARS-CoV-2 RNA by PCR. In hospitalized suspect patients, who tested negative on both swabs, extensive retesting was performed. The sensitivity of NP versus combined OP/N swab sampling on admission and the correlation between viral RNA loads recovered was investigated.Results 35 patients were diagnosed with SARS-CoV-2 by means of either NP or OP/N sampling. The paired swabs were both positive in 31 patients. The one patient who tested negative on both NP and OP/N swab on admission, was ultimately diagnosed on bronchoalveolar lavage fluid. A strong correlation was found between the viral RNA loads of the paired swabs (r = 0.76; P < 0.05). The sensitivity of NP and OP/N analysis in hospitalized patients (n = 28) was 89.3% and 92.7% respectively.Conclusions This study demonstrates equivalence of NP and OP/N sampling for detection of SARS-CoV-2 by means of rRT-PCR. Sensitivity of both NP and OP/N sampling is very high in hospitalized patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding is provided by the epmloyers of the authors (Ghent University and Ghent University Hospital). No funding by third parties for any aspect of the submitted work was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ghent University Hospital Ethical Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data are available upon request